Sanofi Creates Ophtho Division through Earn-Out Acquisition of Fovea
This article was originally published in The Pink Sheet Daily
Executive Summary
By buying its Paris-based neighbor, Sanofi-Aventis creates an ophthalmology division and a chance to license more.
You may also be interested in...
With Precedents In Place, GenSight Eyes Gene Therapies For Orphan Disorders
The Paris-based start-up has raised €32 million from venture investors to address two orphan eye disorders, taking advantage of new research and manufacturing techniques in gene therapy.
NicOx Kicks Off Specialty Ophthalmics Transformation With Altacor Buy
France's NicOx, aiming to transform into a specialty ophthalmology company after several late-stage disappointments, announced plans to acquire VC-backed U.K startup Altacor.
Belgium's Amakem Raises €18 million In Europe's Largest Series A So Far In 2011
Belgian start-up raises record-breaking €18 million A round to take rho kinase inhibitor glaucoma candidate to clinical proof-of-concept.